Nicotinamide Plus Pyruvate for Glaucoma: Looking Beyond the Global Field Score

Glaucoma trials often summarize vision with one global visual-field number. A phase 2 analysis indexed as PMID 42517851 asked whether nicotinamide plus pyruvate produced local improvements that a single score can miss.

Why topography matters

Open-angle glaucoma damages the optic nerve in patterns that are not uniform. A patient can feel a change in one part of the field while the average index barely moves. Mapping where improvement or decline occurs helps researchers—and eventually clinicians—see treatment effects more clearly.

What the analysis reported

In this secondary look at a randomized phase 2 trial of nicotinamide combined with pyruvate for open-angle glaucoma, the authors found local visual-field improvements that global measures did not fully capture. The queue takeaway for this paper is exactly that: topography revealed gains missed by summary scores. The work does not by itself prove that over-the-counter supplements should replace drops, laser, or surgery.

Cautious patient guidance

• Do not stop prescribed glaucoma therapy to try vitamins.
• If you take nicotinamide or related supplements, tell every doctor; dose and purity vary widely among products.
• Ask whether your visual fields are reviewed point-by-point, not only by the mean deviation.
• Keep follow-up intervals even when you feel fine—most glaucoma change is silent.

How we monitor glaucoma

At Khanna Vision Institute we combine pressure checks, optic-nerve imaging, and visual fields, and we discuss when a medicine, laser, or surgical step is the safer path. Nutritional studies are interesting adjunct science, not a do-it-yourself protocol.

What “phase 2” means for patients

Phase 2 studies explore signals and dosing; they are not final proof. Global field indices remain useful for clinic tracking, but this analysis is a reminder to look at the map of the field when something seems clinically better or worse than the summary score suggests. Bring prior printouts to visits so small sector changes are not overlooked.

For more on weighing eye-care options and evidence, see laservisioncost.com.

Source: A Topographical Analysis of Visual Field Improvement in a Phase 2 Randomized Trial of Nicotinamide and Pyruvate for Open-Angle Glaucoma (Investigative Ophthalmology & Visual Science (PubMed PMID 42517851), 2026). This article is an educational summary written by Khanna Vision Institute and is not a substitute for medical advice.